Council for Clinical Research Subject Safety and Data Integrity Blows the Whistle on Fraud in Clinical Drug Testing

Share Article

The Council For Clinical Research Subject Safety & Data Integrity (CCRSSDI) has blown the whistle on widespread fraud in the clinical drug trial world. Two time Emmy© winning reporter Kathy McDevitt led an investigative team from CCRSSDI to record subjects committing fraud. Her investigation led to on-air confessions by two such subjects on the nature and the extent of the fraud in the industry. Ms. McDevitt and CCRSSDI have jointly released a documentary tilted "Pervasive Fraud in the Clinical Trial World". It is available on the CCRSSDI website. Copies of the DVD may also be requested by the video.

Council for Clinical Research Subject Safety and Data Integrity

Pervasive Fraud in the Clinical Trial World

The Council for Clinical Research Subject Safety & Data Integrity (CCRSSDI) has blown the whistle on widespread fraud in the Clinical Drug Trial world.

Two time Emmy© winning reporter Kathy McDevitt led an investigative team from CCRSSDI to record Subjects committing fraud. Her investigation led to on-air confessions by two such subjects on the nature and the extent of the fraud in the industry

Ms. McDevitt and CCRSSDI have jointly released a documentary tilted "Pervasive Fraud in the Clinical Trial World" . It is available on the CCRSSDI website. Copies of the DVD may also be requested by the video.

Among the findings in the documentary:

  • Multiple simultaneous trial enrollments by Subjects
  • Inability of research sites to check for dual clinical trial enrollments
  • No single record of all the studies a subject has taken
  • Inability to verify amount of actual drug usage by a Subject in a Study
  • Potential for flawed results in Studies

"I was shocked by how lax the identification process is for potential Study Subjects", said Kathy McDevitt. "I always had assumed that a thorough identification and verification was required to enroll qualified patients in studies for drugs that you and I take"

Kerri Weingard, the Director of CCRSSDI, further adds "We here at the Council have consistently raised this issue. Many members of this Council run their own Study Sites and we have seen the level of fraud increase year after year. Unfortunately, no steps are being taken by the industry as a whole to combat this problem. If this problem is left unchecked, the whole industry will suffer and public confidence in our Drug Testing process will be fundamentally undermined"

CCRSSDI has led the charge on this issue. Its charter clearly defines that the primary goal of CCRSSDI is to ensure that every study by every site and every sponsor utilizes and identification and verification process to ensure that there is no fraud occurring and that subjects are not dual-enrolled or have been expelled from previous studies.

Download the explosive documentary “Pervasive Fraud in the Clinical Trial World”, at http://www.CouncilForClinicalResearch.com

For further information please contact Kerri Weingard, Director, Council for Clinical Research Subject Safety & Data Integrity at KWeingard(at)CouncilForClinicalResearch(dot)com or 646-225-6624

Council for Clinical Research Subject Safety & Data Integrity is composed of established members of the medical profession. Its goal is to ensure that our testing process for Clinical Research Trials remains error free and that Subject Safety is always assured. Our meetings are open to all. For further information please email us at info(at)CouncilForClinicalResearch(dot)com.

###

Share article on social media or email:

View article via:

Pdf Print